VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 6 filers reported holding VERTEX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,469,000 | -18.3% | 28,700 | -24.5% | 0.00% | -25.0% |
| Q1 2016 | $3,021,000 | -10.4% | 38,000 | +41.8% | 0.00% | 0.0% |
| Q4 2015 | $3,372,000 | -31.3% | 26,800 | -43.1% | 0.00% | -20.0% |
| Q3 2015 | $4,905,000 | -73.4% | 47,100 | -68.5% | 0.01% | -68.8% |
| Q2 2015 | $18,461,000 | +178.4% | 149,500 | +166.0% | 0.02% | +166.7% |
| Q1 2015 | $6,630,000 | -40.1% | 56,200 | -39.7% | 0.01% | -45.5% |
| Q4 2014 | $11,072,000 | -2.3% | 93,200 | -7.6% | 0.01% | -8.3% |
| Q3 2014 | $11,332,000 | -36.7% | 100,900 | -46.6% | 0.01% | -40.0% |
| Q2 2014 | $17,895,000 | +61.0% | 189,000 | +20.2% | 0.02% | +53.8% |
| Q1 2014 | $11,117,000 | -16.5% | 157,200 | -12.3% | 0.01% | -23.5% |
| Q4 2013 | $13,315,000 | +107.6% | 179,200 | +111.8% | 0.02% | +70.0% |
| Q3 2013 | $6,414,000 | -11.4% | 84,600 | -6.6% | 0.01% | -16.7% |
| Q2 2013 | $7,236,000 | – | 90,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMC-Chicago, LLC | 47,200 | $14,871,304 | 0.02% |
| SIMPLEX TRADING, LLC | 62,100 | $19,565 | 0.02% |
| GROUP ONE TRADING, L.P. | 14,300 | $4,505,501 | 0.02% |
| JANE STREET GROUP, LLC | 55,200 | $17,391,864 | 0.01% |
| Allianz Asset Management GmbH | 11,200 | $3,528,784 | 0.01% |
| SG Americas Securities, LLC | 11,000 | $130 | 0.00% |
| JPMORGAN CHASE & CO | 23,200 | $7,310,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |